Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Haw Par Corporation Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 2.60B | 11.4x | 2.12 | SGD 11.73 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tianjin Zhongxin Pharma Group | Singapore | Healthcare | Pharmaceuticals | SGD 2.43B | 6.1x | 0.08 | SGD 3.16 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hyphens Pharma | Singapore | Healthcare | Pharmaceuticals | SGD 92.66M | 10x | 0.54 | SGD 0.30 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.8% Upside | Upgrade to Pro+ | |
IX Biopharma Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 15.98M | -1.8x | -0.3 | SGD 0.02 | 5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharmesis International Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 13.95M | 8.8x | 0.04 | SGD 0.44 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Suntar Eco-City Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 8.03M | 5.5x | 0 | SGD 0.13 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |